First City Capital Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$275K Hold
2,175
0.13% 143
2026
Q1
$303K Hold
2,175
0.16% 129
2025
Q4
$267K Sell
2,175
-100
-4% -$12.2K 0.14% 139
2025
Q3
$253K Sell
2,275
-21
-0.9% -$2.39K 0.14% 137
2025
Q2
$255K Hold
2,296
0.15% 135
2025
Q1
$257K Buy
2,296
+5
+0.2% +$516 0.15% 130
2024
Q4
$212K Buy
+2,291
New +$206K 0.11% 147
2023
Q2
Sell
-2,477
Closed -$204K 173
2023
Q1
$204K Sell
2,477
-32
-1% -$2.65K 0.12% 161
2022
Q4
$215K Buy
+2,509
New +$199K 0.13% 153
2021
Q4
Sell
-3,027
Closed -$211K 170
2021
Q3
$211K Sell
3,027
-200
-6% -$14.1K 0.12% 161
2021
Q2
$229K Hold
3,227
0.13% 154
2021
Q1
$218K Buy
+3,227
New +$208K 0.13% 151
2020
Q4
Sell
-5,446
Closed -$349K 175
2020
Q3
$349K Buy
5,446
+1,902
+54% +$132K 0.13% 140
2020
Q2
$273K Buy
3,544
+350
+11% +$26.8K 0.21% 112
2020
Q1
$239K Sell
3,194
-300
-9% -$20.7K 0.23% 100
2019
Q4
$227K Sell
3,494
-1,733
-33% -$113K 0.16% 131
2019
Q3
$331K Sell
5,227
-1,500
-22% -$98.1K 0.24% 107
2019
Q2
$454K Buy
6,727
+100
+2% +$6.58K 0.33% 91
2019
Q1
$431K Sell
6,627
-1,550
-19% -$103K 0.31% 94
2018
Q4
$511K Sell
8,177
-2,450
-23% -$171K 0.4% 78
2018
Q3
$821K Buy
10,627
+1,100
+12% +$83.1K 0.55% 64
2018
Q2
$675K Sell
9,527
-100
-1% -$7.06K 0.48% 69
2018
Q1
$726K Hold
9,627
0.54% 62
2017
Q4
$690K Sell
9,627
-1,050
-10% -$79.7K 0.47% 68
2017
Q3
$865K Sell
10,677
-150
-1% -$11.5K 0.6% 57
2017
Q2
$766K Sell
10,827
-155
-1% -$10.3K 0.56% 62
2017
Q1
$746K Buy
10,982
+52
+0.5% +$3.66K 0.55% 62
2016
Q4
$783K Buy
+10,930
New +$812K 0.59% 58
2015
Q4
Sell
-3,395
Closed -$333K 674
2015
Q3
$333K Buy
+3,395
New +$377K 0.25% 101
2015
Q2
Sell
-2,745
Closed -$269K 620
2015
Q1
$269K Buy
2,745
+70
+3% +$7.11K 0.19% 111
2014
Q4
$252K Hold
2,675
0.17% 119
2014
Q3
$285K Sell
2,675
-300
-10% -$29.4K 0.2% 115
2014
Q2
$247K Buy
+2,975
New +$232K 0.18% 122
2014
Q1
Sell
-2,975
Closed -$223K 627
2013
Q4
$223K Buy
+2,975
New +$207K 0.18% 135

Other funds holding GILD

First City Capital Management's GILD Position: Q2 2026 in Review

First City Capital Management held its Gilead Sciences (GILD) position steady in Q2 2026 at 2,175 shares worth $275K. The position accounts for 0.13% of the portfolio, ranked #143.

First City Capital Management first reported a position in GILD in Q4 2013 and has held it in 34 quarters since. The position peaked at $865K in Q3 2017. 690 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • First City Capital Management held 2,175 shares of Gilead Sciences worth $275K as of Q2 2026.
  • First City Capital Management left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.13% of First City Capital Management's portfolio in Q2 2026, its #143 holding.
  • First City Capital Management first reported a position in Gilead Sciences in Q4 2013 and has held it in 34 quarters since.
  • First City Capital Management's Gilead Sciences position peaked at $865K in Q3 2017.
  • 690 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on First City Capital Management's 13F filing for Q2 2026, filed 13 Jul 2026.